Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer

Background: Up to 20% of women diagnosed with tubo-ovarian carcinoma carry a germline pathogenic variant in a cancer-predisposing gene (e.g., BRCA1/BRCA2). Identifying these variants can help to inform eligibility for therapies, guide surveillance and prevention of new primary cancers, and assess ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadinsky, Michaela Bercovitch, Power, Joanne, Ambrosio, Enza, Palma, Laura, Zeng, Xing, Foulkes, William D., Weber, Evan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139592/
https://www.ncbi.nlm.nih.gov/pubmed/35621678
http://dx.doi.org/10.3390/curroncol29050288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139592/
https://www.ncbi.nlm.nih.gov/pubmed/35621678
http://dx.doi.org/10.3390/curroncol29050288

Ejemplares similares